SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?


To: Hawkmoon who wrote (716)8/22/1998 3:59:00 PM
From: bmart  Read Replies (1) | Respond to of 26163
 
Mr. Reece,
We have been through this. I suggest you refer to what the FDA is concerned with. The issues you raise are simply not relevant. The AIDS creme is currently going through ICAP in-vitro testing because it must to be considered for submission for FDA approval. AZNT phytogenic products are dietary supplements that do not require FDA approval. Do you understand that, if not I suggest you contact the FDA.

RB



To: Hawkmoon who wrote (716)8/22/1998 4:05:00 PM
From: bmart  Respond to of 26163
 
Mr Reece,
........... "I do question when insiders find themselves possessing for 80% of the
current O/S shares and not discussing the terms of the conversion to
preferred. I also question the lack of substantial revenues and cash
reserves..."

Mr. Reece,
AZNT has been very public and vocal aboutthe reasons for cancelling all common stock in leiu of preferred. Have you done any diligence on this, this is easily obtainable and also explains why the shorts are being squeezed in the process.
You are not aware of financials because of the evaluation by the SEC of putting a value on an 'intellectual property' has yet to be determined. I believe it will be very soon , which will allow the auditing of the financials.
This information is easily obtainable Mr. Reece.

RB